Computer study of tumor samples points to a gene to test in glioblastoma
Original title: Integrative transcriptomic, spatial and functional-genomic analysis identifies a UFMylation-related vascular-stromal program and prioritizes WWTR1 in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This is an early idea from computer study of tumor data, and no treatment has been tested.
The short version
Researchers used computers to study tumor data and found one gene worth testing in the lab.
What was studied. Researchers looked at gene activity data from 518 glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary tumors. They also checked other data sets, including one with 10 samples, to see where in the tumor certain genes were active.
What they found. They found a group of genes that tend to switch on together. This group was most active in the cells that line and support blood vessels, not in the cancer cells themselves. Tumors with more of this activity were linked to a somewhat higher risk of dying, but that link got weaker when other health factors were counted. The study picked a gene called WWTR1 as a good one to test next.
What this means, and what it doesn't
What it could mean: This gives scientists a new idea to test in the lab. It may help them learn how the blood vessel areas of glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary work.
What it doesn't mean: This is not a new treatment. The work was done on computers with stored tumor data. No patients were treated. WWTR1 still needs to be tested in the lab first. This is very early research, far from everyday care, and it is not a cure.
Source: PubMed, September 16, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.